Fairvalue-Calculator Fairvalue-Calculator
EN DE

IMB Dx, Inc (461030) Fair Value & Analysis

Healthcare · KR · Market cap 61.1B KRW

Price3,525 KRW
Fair Value5,386 KRW
Upside+52.8%
Quality95/100
Evidence: Low Range 4,039 KRW – 6,732 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

IMB Dx, Inc (461030) currently trades at 3,525 KRW, while our model-based Fair Value estimate is 5,386 KRW — implying the stock looks roughly 52.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

IMB Dx, Inc. provides liquid biopsy platform in South Korea. It offers AlphaLiquid Platform that provides circulation-tumor DNA-based precision diagnostics solutions across various stages of cancer for patients, survivors, and individuals; AlphaLiquid HRR for diagnostics of targeted therapies, utilizing liquid biopsy profiling technology; and AlphaLiquid 100 test, a tool that enables the detection of biomarkers across 118 cancer-related genes through one blood test. The company also provides CancerDetect, a liquid biopsy platform for the early detection of cancer recurrence post-surgery; and CancerFind, a blood-based test for various cancer early detection. IMB Dx, Inc. was founded in 2018 and is based in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -34% Danaher Corporation (DHR) -37% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -54% Lonza Group (LZAGY) -59% Agilent Technologies, Inc (A) -50%

Frequently asked questions

Is IMB Dx, Inc (461030) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 5,386 KRW versus a price of 3,525 KRW — about +53% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 461030?
Our 21-model fair value for IMB Dx, Inc is 5,386 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 3,525 KRW.
What is the quality score of 461030?
IMB Dx, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.